Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases
- 16 November 2007
- journal article
- review article
- Published by Springer Nature in Amino Acids
- Vol. 35 (1), 29-36
- https://doi.org/10.1007/s00726-007-0606-0
Abstract
Advanced glycation end-products (AGEs) are formed from the so-called Amadori products by rearrangement followed by other reactions giving rise to compounds bound irreversibly. The structure of some of them is shown and the mechanism of formation is described. Several AGE binding molecules (Receptors for AGE, RAGE) are known and it is thought that many of the effects caused by AGEs are mediated by RAGE. Some of these were shown to be toxic, and called TAGE. The mechanism of detoxification of glyoxal and methylglyoxal by the glyoxalase system is described and also the possibility to eliminate glycated proteins by deglycation enzymes. Compounds able to inhibit AGEs formation are also taken into consideration.Keywords
This publication has 42 references indexed in Scilit:
- Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brainNeuroscience Letters, 2004
- Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosisJournal of Hepatology, 2004
- Fructosamine 3-kinase-related protein and deglycation in human erythrocytesBiochemical Journal, 2004
- Glyceraldehyde-derived advanced glycation end products in Alzheimer?s diseaseActa Neuropathologica, 2004
- Role for glyoxalase I in Alzheimer's diseaseProceedings of the National Academy of Sciences, 2004
- Modulation of in vivo 3-deoxyglucosone levelsBiochemical Society Transactions, 2003
- Glyoxalase I inhibitors in cancer chemotherapyBiochemical Society Transactions, 2003
- The polyamines spermine and spermidine protect proteins from structural and functional damage by AGE precursors: a new role for old molecules?Life Sciences, 2003
- AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?Biogerontology, 2001
- Amadorins: Novel Post-Amadori Inhibitors of Advanced Glycation ReactionsBiochemical and Biophysical Research Communications, 1999